Contact
Please use this form to send email to PR contact of this press release:
European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
TO:
Please use this form to send email to PR contact of this press release:
European Medicines Agency Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer's Disease
TO: